ClinicalTrials.Veeva

Menu

Impact of the CT Scan in Patients With Suspected Covid-19 (SCAN-COV-HUS)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

COVID-19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The diagnostic performance of the scanner in the indication of suspected Covid-19 is not yet well known, especially in comparison with the results of RT-PCR.

The potential use of the scanner as a tool for quantifying the severity of Covid-19 disease is not yet well established, especially the variations between readers or between measurement techniques.

The impact of the scanner in predicting the fate of patients with confirmed Covid-19 is not yet known.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Adult patient (≥18 years old)
  • Patient admitted to Strasbourg University Hospitals for suspicion of Covid-19, between 03/01/2020 and 04/29/2020
  • Availability of at least one chest CT scan during hospitalization
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Non-inclusion criteria

  • Patient who expressed his opposition to participating in the study
  • Patient under legal protection
  • Patient under guardianship or guardianship

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Mickaël OHANA, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems